<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">JSLS</journal-id>
      <journal-id journal-id-type="iso-abbrev">JSLS</journal-id>
      <journal-id journal-id-type="hwp">jsls</journal-id>
      <journal-id journal-id-type="pmc">jsls</journal-id>
      <journal-id journal-id-type="publisher-id">JSLS</journal-id>
      <journal-title-group>
        <journal-title>JSLS : Journal of the Society of Laparoendoscopic Surgeons</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1086-8089</issn>
      <issn pub-type="epub">1938-3797</issn>
      <publisher>
        <publisher-name>Society of Laparoendoscopic Surgeons</publisher-name>
        <publisher-loc>Miami, FL</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24398216</article-id>
      <article-id pub-id-type="pmc">3866078</article-id>
      <article-id pub-id-type="publisher-id">12-08-159</article-id>
      <article-id pub-id-type="doi">10.4293/108680813X13654754534918</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Reports</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Ovarian Lymphoma and Hydronephrosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Volpi</surname>
            <given-names>Eugenio</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Department of Obstetrics and Gynecology, Ospedale S. Andrea, LA Spezia, Italy.</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bernardini</surname>
            <given-names>Luca</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Obstetrics and Gynecology, Ospedale S. Andrea, LA Spezia, Italy.</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Angeloni</surname>
            <given-names>Moira</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Obstetrics and Gynecology, Ospedale S. Andrea, LA Spezia, Italy.</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gogna</surname>
            <given-names>Paolo</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Urology, Ospedale S. Bartolomeo, Sarzana, LA Spezia, Italy.</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Intersimone</surname>
            <given-names>Donatella</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Pathology, Ospedale S. Andrea, LA Spezia, Italy.</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fedeli</surname>
            <given-names>Franco</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Pathology, Ospedale S. Andrea, LA Spezia, Italy.</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <corresp>Address correspondence to: Eugenio Volpi, MD, PhD, <addr-line>Ospedale S. Andrea, Via Vittorio Veneto, 197, 19124, La Spezia, Italy</addr-line>. Telephone: <phone>,+39&#x2013;018-753&#x2013;3450</phone>, Fax: <fax>+39&#x2013;018-753&#x2013;3309</fax>, E-mail: <email>eugenio.volpi@hotmail.com</email>.</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Oct-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>17</volume>
      <issue>4</issue>
      <fpage>668</fpage>
      <lpage>671</lpage>
      <permissions>
        <copyright-statement>&#xA9; 2013 by JSLS, Journal of the Society of Laparoendoscopic Surgeons.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Society of Laparoendoscopic Surgeons, Inc.</copyright-holder>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/us/">http://creativecommons.org/licenses/by-nc-nd/3.0/us/</ext-link>), which permits for noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited and is not altered in any way.</license-p>
        </license>
      </permissions>
      <self-uri xlink:title="pdf" xlink:type="simple" xlink:href="jls00413000668.pdf"/>
      <abstract abstract-type="precis">
        <p>This report discusses the association of ovarian lymphoma and hydroureteronephrosis managed by laparoscopic surgery and endoscopy.</p>
      </abstract>
      <abstract>
        <sec>
          <title>Introduction:</title>
          <p>Ovarian lymphoma is a rare entity, and hydronephrosis from lymphoma is even rarer. Most reports describe a laparoscopic approach to the disease, but we report a case of hydroureteronephrosis associated with ovarian lymphoma managed completely by mini-invasive techniques.</p>
        </sec>
        <sec>
          <title>Case Report:</title>
          <p>A 51-year-old woman was referred to us for back pain and renal colic and computed tomography scan findings of right hydroureteronephrosis and a mass in the right mesorectum and uterosacral ligament.</p>
          <p>After magnetic resonance imaging was performed, the patient underwent laparoscopic adnexectomy and ureterolysis after ureteroscopy and stenting. Histology results showed diffuse B-cell lymphoma of the ovary occluding the ureter without infiltration. The patient has undergone 6 cycles of chemotherapy.</p>
        </sec>
        <sec>
          <title>Discussion:</title>
          <p>This is the first report to describe ovarian lymphoma and hydroureteronephrosis managed completely by laparoscopic surgery and endoscopy. Frequency in clinical practice, differential diagnosis, and endoscopic approach are discussed. The advantages of a multidisciplinary endoscopic team are underlined.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Ovarian lymphoma</kwd>
        <kwd>Ureterolysis</kwd>
        <kwd>Laparoscopic surgery</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Ovarian lymphoma is a rare disease presenting in approximately 0.5% of all patients undergoing surgery for ovarian mass and accounting for approximately 1.5% of all ovarian tumors.<sup><xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B3">3</xref></sup> Most of the literature relies on case reports of large masses that are managed like ovarian cancer.<sup><xref ref-type="bibr" rid="B4">4</xref>&#x2013;<xref ref-type="bibr" rid="B6">6</xref></sup> Furthermore, lymphomas involving the ureter precociously are even rarer.<sup><xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref></sup></p>
      <p>We report a case of lymphoma involving the ovary and the ureter, presenting with hydroureteronephrosis, which was managed exclusively by combined endoscopic surgery and chemotherapy.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 51-year-old patient was referred to us for back pain and hydroureteronephrosis. She was still menstruating regularly and had already been treated for renal colic and complained about weight loss, but was completely free of other symptoms. A previous computed tomography (CT) scan had visualized hydroureteronephrosis with a 4-mm possible stone within the right ureter and solid tissue at the level of the mesorectum and uterosacral ligament on the same side.</p>
      <p>Abdominal examination did not show any mass or swelling. However, pelvic examination revealed an approximately 2-cm nodule in the rectovaginal septum on the right side that was not painful on palpation, as well as 2 smaller nodules in the vesicovaginal septum located below the bladder-vescical trigonum. Transvaginal ultrasound showed the nodules and thickened endometrium, suggesting the secretory phase and that the right ovary was only slightly enlarged. A magnetic resonance imaging scan was requested, which showed the nodules and more lesions located in the mesorectum. Small lymph nodes (7&#x2013;8 mm) were visible in the pelvis. The right ureter was thickened in the pelvic part and dilated in the upper part. Magnetic resonance imaging findings also showed an endoureteral mass, suggesting either endometriosis or a transitional epithelial tumor, but not a stone. On visualization, the ovaries were considered normal.</p>
      <p>Chest radiography revealed no abnormalities. Blood counts were normal, with the exception of iron deficiency, and were negative for the CA-125 antigen.</p>
      <p>We decided to access the pelvis laparoscopically to perform ureterolysis and biopsies in the rectovaginal septum, while ureteroscopy and eventual stenting could be performed during the same surgery.</p>
      <p>At surgery, ureteroscopy was performed and no lesion was found in the ureteral lumen, so stenting was done. Meanwhile, laparoscopy was performed and the right ovary was found to be strictly adherent to the ovarian fossa infiltrated from the infundibulopelvic ligament by whitish fibrous tissue that also infiltrated the broad ligament peritoneum and the retroperitoneum placed below, between the gonadal vessels to the uterine artery and the anterior parametrium. Then laparoscopic right adnexectomy and ureterolysis were completed, freeing the ureter from the surrounding tissue up to the point where the ureter was healthy and below the uterine artery. The infundibulopelvic ligament was severed well above the pelvic brim to cut into healthy tissue. The peritoneum of the broad ligament, that of the ovarian fossa, and the solid retroperitoneal tissue surrounding the ureter were removed together with the ovary. The ureter was actually compressed by the fibrous tissue but not infiltrated, and no other procedure was accomplished. The abdomen, the uterus, and the contralateral ovary did not show any lesion, so they were not removed. No endometriosis was visible in the pelvis, so we ended the procedure with the belief that an infiltrating tumor was the cause of stenosis and then waited for a positive diagnosis.</p>
      <p>The patient's postoperative course was normal, and she was discharged with the stent on the fourth postoperative day because of hematuria.</p>
      <p>Histology demonstrated B-cell lymphoma <bold>(<xref ref-type="fig" rid="F1">Figure 1</xref>)</bold> with germinal-like phenotype infiltrating the ovary with diffuse growth. B-cell lymphoma originated from the peripheral fraction. Cytology results of the peritoneal washing were negative. Immunohistochemistry findings demonstrated reactivity to CD20 and BCL-6 and weak reactivity to CD10. No reactivity was shown to CD3, CD30, IRF4, IRTA1-, and BCL-2. The proliferative fraction was evaluated to be 60% to 70%.</p>
      <fig id="F1" position="float">
        <label>Figure 1.</label>
        <caption>
          <p>Histology of the B-cell lymphoma infiltrating the ovary.</p>
        </caption>
        <graphic xlink:href="jls0021329970001"/>
      </fig>
      <p>Staging was performed by computed tomography scan of the thorax and positron emission tomography (PET) scan. No lesions could be visualized using either diagnostic tool.</p>
      <p>According to the American Joint Commission on Cancer classification system,<sup><xref ref-type="bibr" rid="B9">9</xref></sup> the disease was confirmed to be stage IIE.</p>
      <p>The patient has undergone 6 cycles of chemotherapy.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Lymphoma of the ovary is a rare condition, and most of the reported series are case reports.<sup><xref ref-type="bibr" rid="B4">4</xref>&#x2013;<xref ref-type="bibr" rid="B8">8</xref></sup> Furthermore, the majority of patients with ovarian lymphoma are in the advanced stages of the disease<sup><xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B10">10</xref></sup> or have large ovarian masses.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref></sup> Thus, most of the patients with large masses also undergo laparoscopic staging for ovarian cancer,<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref></sup> but lymphoma requires medical treatment more than surgical treatment. In addition, hydronephrosis as a first symptom of lymphoma is rarely reported,<sup><xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref></sup> but this is the first time we have seen the association between hydronephrosis and ovarian lymphoma. The question about the origin of primary ovarian lymphoma is debated,<sup><xref ref-type="bibr" rid="B2">2</xref></sup> and in this case, the exact origin of the disease is unknown. However, the involvement of the ovary as a secondary site is believed to be a late symptom of the disease.<sup><xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B10">10</xref></sup></p>
      <p>We want to underline that complete endoscopic access (both urological and gynecological) can limit the aggressiveness of surgery primarily in patients for whom the diagnostic challenge is great. The choice for laparoscopy instead of a direct biopsy of the palpable nodules was made because of the difficulty in performing such biopsies at the level of the vesicovaginal fascia at the trigonal level and in the rectovaginal septum from below. Ureteral reimplantation was planned in case the disease directly infiltrated the ureter. No consensus was obtained for complete staging in the case of ovarian malignancy.</p>
      <p>Laparoscopic ureterolysis is a difficult procedure that is mostly indicated in retroperitoneal fibrosis.<sup><xref ref-type="bibr" rid="B11">11</xref>&#x2013;<xref ref-type="bibr" rid="B13">13</xref></sup> Keehn et al<sup><xref ref-type="bibr" rid="B12">12</xref></sup> reported 3 cases of ureterolysis in lymphoma. However, minimally invasive surgery is now becoming the standard approach for ureterolysis.<sup><xref ref-type="bibr" rid="B11">11</xref>&#x2013;<xref ref-type="bibr" rid="B13">13</xref></sup> In gynecology, the most frequent disease associated with ureteral stenosis is endometriosis, so ureterolysis is frequently performed.<sup><xref ref-type="bibr" rid="B14">14</xref></sup></p>
      <p>In our experience, freeing the ureter from endometriosis does not routinely require stenting. We have almost never recommended ureteral catheterization in these patients, but in this case, placing a stent in the ureter was a precautionary procedure because we were uncertain about the presence of a stone or of an endoureteric lesion, and because in tumors the catheter can protect the ureter in cases that involve radiotherapy. Some authors suggest that routine prophylactic stenting may be beneficial in gynecological procedures,<sup><xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref></sup> but most of the literature<sup><xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref></sup> and a large prospective study<sup><xref ref-type="bibr" rid="B19">19</xref></sup> do not show the benefits of the procedure.</p>
      <p>Diffuse large B-cell lymphomas are most frequently seen in the genital tract, accounting for approximately 90% of the cases.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref></sup> In our case, histology and histochemistry demonstrated B-cell lymphoma. A frozen section taken for biopsy was not requested because the surgery suggested sarcoma or lymphoma as a possible diagnosis. A frozen biopsy section is limited in diagnosing diseases, and complete staging and debulking is requested only for sarcoma.</p>
      <p>There are also problems in the staging procedure. Now the standard use of PET scan in lymphoma is suggested<sup><xref ref-type="bibr" rid="B20">20</xref></sup> for staging and for follow-up of patients, even if not all authors agree on this.<sup><xref ref-type="bibr" rid="B21">21</xref></sup> Reported sensitivity for lymphoma is approximately 80% to 90% also according to the subtype of lymphoma and to its metabolic activity. In this case, however, PET scan was negative in the pelvis, and, according to our pelvic examination, magnetic resonance with diffusion-weighted imaging, which enhances the sensitivity of the technique, was much more accurate in describing the lesions <bold>(<xref ref-type="fig" rid="F2">Figures 2</xref><xref ref-type="fig" rid="F3"/>&#x2013;<xref ref-type="fig" rid="F4">4</xref>).</bold></p>
      <fig id="F2" position="float">
        <label>Figure 2.</label>
        <caption>
          <p>Magnetic Resonance Imaging: axial scan showing hydronephrosis.</p>
        </caption>
        <graphic xlink:href="jls0021329970002"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3.</label>
        <caption>
          <p>Magnetic Resonance Imaging: transversal scan of the lesion in the vesico-vaginal septom.</p>
        </caption>
        <graphic xlink:href="jls0021329970003"/>
      </fig>
      <fig id="F4" position="float">
        <label>Figure 4.</label>
        <caption>
          <p>Magnetic Resonance Imaging: diffusion weighted scan showing the same lesion of <xref ref-type="fig" rid="F3">Figure 3</xref>.</p>
        </caption>
        <graphic xlink:href="jls0021329970004"/>
      </fig>
      <p>In conclusion, a multidisciplinary endoscopic and laparoscopic team can manage cases in which the diagnosis is difficult, limiting the aggressiveness of surgery, but leaving all chances for therapeutic choice. Ovarian lymphoma is a rare disease, and its presentation with hydroureteronephrosis is even rarer. In this case, the mini-invasive approach has allowed precocious return to normal activity for the patient as well as commencement of chemotherapy.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References:</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Signorelli</surname><given-names>M</given-names></name><name><surname>Maneo</surname><given-names>A</given-names></name><name><surname>Cammarota</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Conservative management in primary genital lymphomas: the role of chemottherapy</article-title>. <source>Gynecol Oncol</source>. <year>2007</year>;<volume>104</volume>:<fpage>416</fpage>&#x2013;<lpage>423</lpage><pub-id pub-id-type="pmid">17049970</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Monterroso</surname><given-names>V</given-names></name><name><surname>Jaffe</surname><given-names>ES</given-names></name><name><surname>Merino</surname><given-names>MJ</given-names></name><name><surname>Medeiros</surname><given-names>LJ</given-names></name></person-group>
<article-title>Malignant lymphomas involving the ovary. A clinicopathologic analysis of 39 cases</article-title>. <source>Am J Surg Pathol</source>. <year>1993</year>;<volume>17</volume>:<fpage>154</fpage>&#x2013;<lpage>170</lpage><pub-id pub-id-type="pmid">8422111</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dimopoulos</surname><given-names>MA</given-names></name><name><surname>Daliani</surname><given-names>D</given-names></name><name><surname>Pugh</surname><given-names>W</given-names></name><name><surname>Gershenson</surname><given-names>D</given-names></name><name><surname>Cabanillas</surname><given-names>F</given-names></name><name><surname>Sarris</surname><given-names>AH</given-names></name></person-group>
<article-title>Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapy</article-title>. <source>Gynecol Oncol</source>. <year>1997</year>;<volume>64</volume>:<fpage>446</fpage>&#x2013;<lpage>450</lpage><pub-id pub-id-type="pmid">9062148</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jung</surname><given-names>IS</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><etal/></person-group>
<article-title>A case of primary ovarian lymphoma presenting as a rectal submucosal tumor</article-title>. <source>J Korean Soc Coloproctol</source>. <year>2012</year>;<volume>28</volume>:<fpage>111</fpage>&#x2013;<lpage>115</lpage><pub-id pub-id-type="pmid">22606652</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bambury</surname><given-names>I</given-names></name><name><surname>Wharfe</surname><given-names>G</given-names></name><name><surname>Fletcher</surname><given-names>H</given-names></name><name><surname>Williams</surname><given-names>E</given-names></name><name><surname>Jaggon</surname><given-names>J</given-names></name></person-group>
<article-title>Ovarian lymphoma</article-title>. <source>J Obstet Gynecol</source>. <year>2011</year>;<volume>31</volume>:<fpage>653</fpage>&#x2013;<lpage>655</lpage><pub-id pub-id-type="pmid">21973136</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ambulkar</surname><given-names>J</given-names></name><name><surname>Nair</surname><given-names>R</given-names></name></person-group>
<article-title>Primary ovarian lymphoma: report of cases and review of literature</article-title>. <source>Leuk Lymph</source>. <year>2003</year>;<volume>44</volume>:<fpage>825</fpage>&#x2013;<lpage>827</lpage></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haitani</surname><given-names>T</given-names></name><name><surname>Shimizu</surname><given-names>Y</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>A case of ureteral malignant lymphoma with concentric thickening of the ureteral wall</article-title>. <source>Hinyokika Kiyo</source>. <year>2012</year>;<volume>58</volume>:<fpage>209</fpage>&#x2013;<lpage>213</lpage><pub-id pub-id-type="pmid">22684262</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fujisawa</surname><given-names>H</given-names></name><name><surname>Takagane</surname><given-names>H</given-names></name><name><surname>Shimosegawa</surname><given-names>K</given-names></name><name><surname>Sakuma</surname><given-names>T</given-names></name></person-group>
<article-title>Primary malignant lymphoma of the ureter: a case report</article-title>. <source>Hinyokika Kiyo</source>. <year>2004</year>;<volume>50</volume>:<fpage>721</fpage>&#x2013;<lpage>724</lpage><pub-id pub-id-type="pmid">15575226</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="book">
<person-group person-group-type="editor"><name><surname>Edge</surname><given-names>SB</given-names></name><name><surname>Byrd</surname><given-names>DR</given-names></name><name><surname>Compton</surname><given-names>CC</given-names></name><etal/></person-group>, eds. <source>AJCC Cancer Staging Manual</source>, <edition>7th ed</edition>
<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer</publisher-name>
<year>2010</year>: pp <fpage>607</fpage>&#x2013;<lpage>611</lpage></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Magri</surname><given-names>K</given-names></name><name><surname>Riethmuller</surname><given-names>D</given-names></name><name><surname>Maillet</surname><given-names>R</given-names></name></person-group>
<article-title>Pelvic Burkitt lymphoma mimicking an ovarian tumor</article-title>. <source>J Obstet Gynecol Biol Reprod</source>. <year>2006</year>;<volume>35</volume>:<fpage>280</fpage>&#x2013;<lpage>282</lpage></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stifelman</surname><given-names>MD</given-names></name><name><surname>Shah</surname><given-names>O</given-names></name><name><surname>Mufarrij</surname><given-names>P</given-names></name><name><surname>Lipkin</surname><given-names>M</given-names></name></person-group>
<article-title>Minimally invasive management of retroperitoneal fibrosis</article-title>. <source>Urology</source>. <year>2008</year>;<volume>71</volume>:<fpage>201</fpage>&#x2013;<lpage>204</lpage><pub-id pub-id-type="pmid">18308083</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Keehn</surname><given-names>AY</given-names></name><name><surname>Mufarrij</surname><given-names>PW</given-names></name><name><surname>Stiefelman</surname><given-names>MD</given-names></name></person-group>
<article-title>Robotic ureterolysis for relief of ureteral obstruction from retroperitoneal fibrosis</article-title>. <source>Urology</source>. <year>2011</year>;<volume>77</volume>:<fpage>1370</fpage>&#x2013;<lpage>1374</lpage><pub-id pub-id-type="pmid">21296397</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seixas-Mikelus</surname><given-names>SA</given-names></name><name><surname>Marshall</surname><given-names>SJ</given-names></name><name><surname>Stephens</surname><given-names>D</given-names></name><name><surname>Blumenfeld</surname><given-names>A</given-names></name><name><surname>Arnone</surname><given-names>ED</given-names></name><name><surname>Guru</surname><given-names>KA</given-names></name></person-group>
<article-title>Robot-assisted laparoscopoic ureterolysis: case report and literature review on the minimally invasive surgical approach</article-title>. <source>JSLS</source>. <year>2010</year>;<volume>4</volume>:<fpage>313</fpage>&#x2013;<lpage>319</lpage><pub-id pub-id-type="pmid">20932393</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Camanni</surname><given-names>M</given-names></name><name><surname>Delpiano</surname><given-names>EM</given-names></name><name><surname>Bonino</surname><given-names>L</given-names></name><name><surname>Deltetto</surname><given-names>F</given-names></name></person-group>
<article-title>Laparoscopic conservative management of ureteral endometriosis</article-title>. <source>Curr Opin Obstet Gynecol</source>. <year>2010</year>;<volume>22</volume>:<fpage>309</fpage>&#x2013;<lpage>314</lpage><pub-id pub-id-type="pmid">20610998</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abu-Rustum</surname><given-names>N</given-names></name><name><surname>Sonoda</surname><given-names>Y</given-names></name><name><surname>Black</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Cystoscopic temporary uretera catheterization during radical vaginal and abdominal trachelectomy</article-title>. <source>Gynecol Oncol</source>. <year>2006</year>;<volume>103</volume>:<fpage>729</fpage>&#x2013;<lpage>731</lpage><pub-id pub-id-type="pmid">16753202</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aungst</surname><given-names>MJ</given-names></name><name><surname>Sears</surname><given-names>CLG</given-names></name><name><surname>Fischer</surname><given-names>JR</given-names></name></person-group>
<article-title>Ureteral stents and retrograde studies: a primer for gynecologist</article-title>. <source>Curr Opin Obstet Gynecol</source>. <year>2009</year>;<volume>21</volume>:<fpage>434</fpage>&#x2013;<lpage>441</lpage><pub-id pub-id-type="pmid">19606030</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kuno</surname><given-names>K</given-names></name><name><surname>Menzin</surname><given-names>A</given-names></name><name><surname>Kauder</surname><given-names>HH</given-names></name><etal/></person-group>
<article-title>Prophylactic ureteral catheterization in gynecologic surgery</article-title>. <source>Urology</source>. <year>1998</year>;<volume>52</volume>:<fpage>1004</fpage>&#x2013;<lpage>1008</lpage><pub-id pub-id-type="pmid">9836545</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schimpf</surname><given-names>MO</given-names></name><name><surname>Gottenger</surname><given-names>EE</given-names></name><name><surname>Wagner</surname><given-names>JR</given-names></name></person-group>
<article-title>Universal ureteral stent placement at hysterectomy to identify ureteral injury: a decision analysis</article-title>. <source>Br J Obstet Gynecol</source>. <year>2008</year>;<volume>114</volume>:<fpage>1151</fpage>&#x2013;<lpage>1158</lpage></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Asada</surname><given-names>H</given-names></name><name><surname>Kuji</surname><given-names>N</given-names></name><name><surname>Yoshimura</surname><given-names>Y</given-names></name></person-group>
<article-title>Ureteral catheter placement during laparoscopic hysterectomy</article-title>. <source>J Obstet Gynecol Res</source>. <year>2008</year>;<volume>34</volume>:<fpage>67</fpage>&#x2013;<lpage>72</lpage><pub-id pub-id-type="pmid">18226132</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Imataki</surname><given-names>O</given-names></name><name><surname>Tamai</surname><given-names>Y</given-names></name><name><surname>Yokoe</surname><given-names>K</given-names></name><name><surname>Furukawa</surname><given-names>T</given-names></name><name><surname>Kawakami</surname><given-names>K</given-names></name></person-group>
<article-title>The utility of FDG-PET for managing patients with malignant lymphoma: analysis of data from a single cancer center</article-title>. <source>Intern Med</source>. <year>2009</year>;<volume>48</volume>:<fpage>1509</fpage>&#x2013;<lpage>1513</lpage><pub-id pub-id-type="pmid">19721294</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baba</surname><given-names>S</given-names></name><name><surname>Abe</surname><given-names>K</given-names></name><name><surname>Isoda</surname><given-names>T</given-names></name><name><surname>Maruoka</surname><given-names>Y</given-names></name><name><surname>Sasaki</surname><given-names>M</given-names></name><name><surname>Honda</surname><given-names>H</given-names></name></person-group>
<article-title>Impact of FDG-PET/CT in the management of lymphoma</article-title>. <source>Ann Nucl Med</source>. <year>2011</year>;<volume>25</volume>:<fpage>701</fpage>&#x2013;<lpage>716</lpage><pub-id pub-id-type="pmid">22037934</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
